Literature DB >> 8371157

Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.

R Fern1, B R Ransom, P K Stys, S G Waxman.   

Abstract

The effects of phenytoin (DPH), carbamazepine (CBZ) and diazepam (DZP) on anoxia-induced injury in CNS white matter were studied using the in vitro rat optic nerve preparation. Optic nerves were subjected to 60 min of anoxia and functional recovery was assessed using the area under the compound action potential. Under normoxic conditions, application of DPH, CBZ and DZP reduced compound action potential area over concentration ranges known to block sodium channels. All three compounds, however, protected against anoxic injury at concentrations below those that inhibited the normoxic compound action potential. Thus, the application of 1 microM DPH, CBZ or DZP during anoxia resulted in compound action potential recovery to 60.0, 53.8 and 69.2% of control, respectively, compared to compound action potential recovery of 34.8% in the absence of drugs (P < .05 in all three cases). In the cases of CBZ and DPH, 60% improvement in recovery from anoxia was produced by concentrations well below those employed clinically to treat epilepsy, suggesting a potential role for these drugs in the protection of CNS white matter from anoxic injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8371157

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

1.  Targeting ion channels for the treatment of autoimmune neuroinflammation.

Authors:  Stefan Bittner; Sven G Meuth
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

2.  Complex interplay between glutamate receptors and intracellular Ca2+ stores during ischaemia in rat spinal cord white matter.

Authors:  Mohamed Ouardouz; Sameh Malek; Elaine Coderre; Peter K Stys
Journal:  J Physiol       Date:  2006-08-31       Impact factor: 5.182

3.  Calcium release from intra-axonal endoplasmic reticulum leads to axon degeneration through mitochondrial dysfunction.

Authors:  Rosario Villegas; Nicolas W Martinez; Jorge Lillo; Phillipe Pihan; Diego Hernandez; Jeffery L Twiss; Felipe A Court
Journal:  J Neurosci       Date:  2014-05-21       Impact factor: 6.167

Review 4.  Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis.

Authors:  Matilde Inglese; Lazar Fleysher; Niels Oesingmann; Maria Petracca
Journal:  Expert Rev Neurother       Date:  2018-01-30       Impact factor: 4.618

Review 5.  Sodium MRI of multiple sclerosis.

Authors:  Maria Petracca; Lazar Fleysher; Niels Oesingmann; Matilde Inglese
Journal:  NMR Biomed       Date:  2015-04-06       Impact factor: 4.044

Review 6.  Phenytoin: neuroprotection or neurotoxicity?

Authors:  Jan M Keppel Hesselink; David J Kopsky
Journal:  Neurol Sci       Date:  2017-05-11       Impact factor: 3.307

7.  Susceptibility of isolated rat facial nerve to anaerobic stress.

Authors:  R Jund; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

8.  Plasma membrane calcium ATPase deficiency causes neuronal pathology in the spinal cord: a potential mechanism for neurodegeneration in multiple sclerosis and spinal cord injury.

Authors:  Michael P Kurnellas; Arnaud Nicot; Gary E Shull; Stella Elkabes
Journal:  FASEB J       Date:  2004-12-02       Impact factor: 5.191

9.  Effects of mexiletine, ginkgo biloba extract (EGb 761), and their combination on experimental head injury.

Authors:  Ahmet Menkü; R Kemal Koç; Vatan Tayfur; Recep Saraymen; Figen Narin; Hidayet Akdemir
Journal:  Neurosurg Rev       Date:  2003-07-12       Impact factor: 3.042

10.  Neuroprotective effect of mexiletine in the central nervous system of diabetic rats.

Authors:  Ozkan Ates; Suleyman R Cayli; Eyup Altinoz; Neslihan Yucel; Ayhan Kocak; Ozcan Tarim; Akif Durak; Yusuf Turkoz; Saim Yologlu
Journal:  Mol Cell Biochem       Date:  2006-03-16       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.